American Stock Exchange Lists ELKS Linked to Genentech, Inc.

American Stock Exchange Lists ELKS Linked to Genentech, Inc.



NEW YORK, Aug. 25  /PRNewswire/ -- The American Stock Exchange(R) (Amex(R))
today began trading Citigroup Global Markets 7.5 % Equity Linked Securities
(ELKS) linked to Genentech, Inc.  Trading under the ticker symbol EKG, 1.8
million shares of the new one-year securities were issued at $10 each with a
maturity date of August 30, 2005.

The security will bear an annual coupon of 7.5 % based on the initial offering
price of $10.  The coupon will be payable February 28, 2005 and again on August
30, 2005.  The ELKS are not subject to redemption by any holder prior to
maturity.  The value of the ELKS at maturity will be based on the performance
of the underlying security.  The maturity payment for each ELKS will equal
either:

   * A fixed number of shares of Genentech, Inc. common stock, or;
   * $10 in cash.



The securities are issued by Citigroup Global Markets.  The Amex specialist
unit is Kellogg Capital Group.

If you would like to receive a copy of the prospectus for EKG, please contact
the Capital Markets Group at the American Stock Exchange at [phone].

The American Stock Exchange(R) (Amex(R)) is the only primary exchange that
offers trading across a full range of equities, options and exchange traded
funds (ETFs), including structured products and HOLDRS(SM).  In addition to its
role as a national equities market, the Amex is the pioneer of the ETF,
responsible for bringing the first domestic product to market in 1993. Leading
the industry in ETF listings, the Amex lists 138 ETFs.  The Amex is also one of
the largest options exchanges in the U.S., trading options on broad-based and
sector indexes as well as domestic and foreign stocks.  For more information,
please visit http://www.amex.com/. 

DATASOURCE: American Stock Exchange



CONTACT:  Media - Lynn Duffy, American Stock Exchange, [phone],

 



Web site:  http://www.amex.com/ 

Copyright